Bristlecone Advisors, LLC Pfizer Inc Transaction History

Bristlecone Advisors, LLC

$1.17 Billion
Q3 2025

A detailed history of Bristlecone Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Bristlecone Advisors, LLC holds 49,316 shares of PFE stock, worth $1.22 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

49,316

Previous 75,493 34.67%

Holding current value

$1.22 Million

Previous $1.83 Million 31.33%

% of portfolio

0.11%

Previous 0.16%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 24, 2025	SELL	$23.29 - $25.88 $609,662 - $677,460	-26,177 Reduced 34.67%	49,316 $1.26 Million
Q2 2025 Aug 04, 2025	SELL	$21.59 - $24.84 $2.72 Million - $3.13 Million	-125,972 Reduced 62.53%	75,493 $1.83 Million
Q1 2025 May 12, 2025	BUY	$25.01 - $27.13 $864,095 - $937,341	34,550 Added 20.7%	201,465 $5.11 Million
Q4 2024 Jan 29, 2025	BUY	$24.8 - $30.19 $1.25 Million - $1.52 Million	50,359 Added 43.21%	166,915 $4.43 Million
Q3 2024 Oct 24, 2024	BUY	$27.7 - $31.39 $700,283 - $793,570	25,281 Added 27.7%	116,556 $3.37 Million
Q2 2024 Jul 25, 2024	BUY	$25.26 - $29.6 $571,810 - $670,055	22,637 Added 32.98%	91,275 $2.55 Million
Q1 2024 Apr 22, 2024	BUY	$25.89 - $29.73 $1.5 Million - $1.73 Million	58,092 Added 550.84%	68,638 $1.9 Million
Q4 2023 Jan 25, 2024	SELL	$26.13 - $33.94 $757 - $984	-29 Reduced 0.27%	10,546 $303,000
Q3 2023 Oct 16, 2023	BUY	$32.09 - $37.51 $962 - $1,125	30 Added 0.28%	10,575 $350,000
Q2 2023 Aug 03, 2023	BUY	$36.12 - $41.79 $18,457 - $21,354	511 Added 5.09%	10,545 $386,000
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $38,129 - $49,639	-968 Reduced 8.8%	10,034 $409,000
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $14,236 - $18,584	341 Added 3.2%	11,002 $563,000
Q3 2022 Oct 27, 2022	BUY	$43.76 - $53.42 $14,046 - $17,147	321 Added 3.1%	10,661 $467,000
Q2 2022 Jul 25, 2022	SELL	$46.53 - $55.17 $1,721 - $2,041	-37 Reduced 0.36%	10,340 $542,000
Q1 2022 Apr 22, 2022	BUY	$45.75 - $56.69 $1,647 - $2,040	36 Added 0.35%	10,377 $537,000
Q4 2021 Jan 19, 2022	BUY	$41.32 - $61.25 $3,842 - $5,696	93 Added 0.91%	10,341 $611,000
Q3 2021 Oct 19, 2021	SELL	$39.25 - $50.42 $19,389 - $24,907	-494 Reduced 4.6%	10,248 $441,000
Q2 2021 Jul 21, 2021	SELL	$35.91 - $40.68 $1,687 - $1,911	-47 Reduced 0.44%	10,742 $421,000
Q1 2021 Apr 30, 2021	SELL	$33.49 - $37.77 $59,980 - $67,646	-1,791 Reduced 14.24%	10,789 $391,000
Q4 2020 Jan 25, 2021	BUY	$33.47 - $42.56 $3,982 - $5,064	119 Added 0.95%	12,580 $463,000
Q3 2020 Oct 20, 2020	BUY	$31.75 - $37.25 $38,608 - $45,296	1,216 Added 10.81%	12,461 $457,000
Q2 2020 Jul 16, 2020	SELL	$30.12 - $36.54 $50,059 - $60,729	-1,662 Reduced 12.88%	11,245 $368,000
Q1 2020 Apr 16, 2020	SELL	$27.03 - $38.62 $486,540 - $695,160	-18,000 Reduced 58.24%	12,907 $421,000
Q4 2019 Jan 21, 2020	BUY	$32.92 - $37.36 $584,626 - $663,476	17,759 Added 135.07%	30,907 $1.21 Million
Q3 2019 Oct 28, 2019	SELL	$32.49 - $42.13 $593,592 - $769,715	-18,270 Reduced 58.15%	13,148 $472,000
Q2 2019 Jul 19, 2019	BUY	$36.98 - $41.52 $658,909 - $739,803	17,818 Added 131.01%	31,418 $1.36 Million
Q1 2019 Apr 23, 2019	BUY	$37.5 - $41.2 $103,012 - $113,176	2,747 Added 25.31%	13,600 $578,000
Q4 2018 Jan 15, 2019	BUY	$38.47 - $43.86 $2,346 - $2,675	61 Added 0.57%	10,853 $474,000
Q3 2018 Oct 22, 2018	BUY	$34.47 - $41.81 $169,730 - $205,872	4,924 Added 83.91%	10,792 $476,000
Q2 2018 Jul 31, 2018	SELL	$32.98 - $35.16 $52,570 - $56,045	-1,594 Reduced 21.36%	5,868 $213,000
Q1 2018 Apr 24, 2018	SELL	$31.91 - $37.02 $112,546 - $130,569	-3,527 Reduced 32.1%	7,462 $265,000
Q4 2017 Jan 30, 2018	BUY	$33.26 - $35.29 $5,255 - $5,575	158 Added 1.46%	10,989 $398,000
Q3 2017 Oct 20, 2017	BUY	$31.0 - $34.15 $335,761 - $369,878	10,831	10,831 $387,000

Others Institutions Holding PFE

# of Institutions

3,319

Shares Held

3.65B

Call Options Held

103M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristlecone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bristlecone Advisors, LLC with notifications on news.

Account

Bristlecone Advisors, LLC Pfizer Inc Transaction History